216 F. Supp. 3d 1017
N.D. Cal.2016Background
- Fitbit developed and marketed wrist-based heart-rate technology called PurePulse in the Charge HR and Surge, and touted "continuous" and "highly accurate" heart-rate tracking in press releases and its IPO/secondary offering prospectuses.
- Charge HR and Surge sales were material to Fitbit’s 2015 revenue growth; the IPO closed June 18, 2015.
- Beginning January 5, 2016, a consumer class action (McLellan) and later media reports and a study alleged significant inaccuracy in Fitbit heart-rate measurements, particularly during exercise; Fitbit stock fell substantially between January and May 2016.
- Lead plaintiff Fitbit Investor Group sued under Exchange Act §10(b)/§20(a) (class period June 18, 2015–May 19, 2016) and Securities Act §§11/15 (IPO purchasers), alleging material misstatements about accuracy and seeking damages.
- Defendants moved to dismiss for failure to plead actionable misstatements, scienter, loss causation, and (for §11) recoverable damages; the court treated the amended complaint as true for the motion-to-dismiss analysis.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Actionable misstatements under §10(b) | Fitbit claimed devices provided continuous, highly accurate heart-rate tracking suitable for exercise; those statements were false | Statements were puffery or not absolute claims of perfect accuracy; post-IPO statements were nonactionable optimism | Court: many challenged statements (press releases, IPO/secondary prospectuses, certain product claims) are sufficiently specific to be actionable at pleading stage — denial of dismissal |
| Scienter (intent or deliberate recklessness) | Allegations of motive (device-driven revenue), insider use, suspicious insider sales, and confidential-witness reports of known inaccuracy together plead a strong inference of scienter | Motive/opportunity and device use alone are insufficient; insider sales not unusual without trading history; some CW statements are unreliable | Court: CWs (data scientist and fitness tester) plus holistic review create a cogent and compelling inference of scienter — denial of dismissal |
| Loss causation for §10(b) | The McLellan filing, media reports, and a study revealed the falsity and caused the stock decline | Those disclosures showed only the possibility of a problem, not the falsity; plaintiffs haven't tied declines to revelations of the misstatements | Court: At pleading stage, allegations that disclosures revealed the inaccuracy and stock decline sufficiently plead loss causation — denial of dismissal |
| §11 liability and recoverable damages (IPO plaintiffs) | IPO registration statements contained materially false statements about accuracy; plaintiffs allege the stock traded below IPO price by suit filing | Prospectus risk disclosures and market movement show plaintiffs cannot recover; negative causation defense applies | Court: Prospectus risk language did not disclose present accuracy problems; plaintiffs adequately allege actionable misstatements and that decline touched on the misstatements — dismissal denied |
Key Cases Cited
- Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (establishes plausibility standard for Rule 12(b)(6))
- Ashcroft v. Iqbal, 556 U.S. 662 (pleading must contain factual allegations to support legal conclusions)
- Tellabs, Inc. v. Makor Issues & Rights, Inc., 551 U.S. 308 (holistic Tellabs inquiry for scienter under PSLRA)
- Zucco Partners, LLC v. Digimarc Corp., 552 F.3d 981 (PSLRA particularity for falsity and scienter in Ninth Circuit)
- Daou Systems, Inc. v. Broudo, 411 F.3d 1006 (particularity requirements and loss causation principles)
- Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (loss causation requires causal connection between misrepresentation and economic loss)
- In re Gilead Sciences Securities Litigation, 536 F.3d 1049 (pleading loss causation plausibly at motion to dismiss)
- Silicon Graphics Inc. Securities Litigation, 183 F.3d 970 (insider trading and scienter analysis factors)
- Kaplan v. Rose, 49 F.3d 1363 (distinguishing puffery from actionable factual misstatements)